







Leadership is the capacity to translate vision into reality.
- Warren Bennis

Leadership is the capacity to translate vision into reality.
- Warren Bennis
Asthesayinggoes, "Failing to prepare is preparing to fail."
Thisringsespeciallytrueinthepharmaceuticalindustry, wherepre-marketingstrategiescansignificantlyinfluencea product'ssuccess.WiththeU.S.pharmaceuticalmarketvaluedat approximately$1.48trillionin2022,effectivepre-marketingis crucialforcompaniesaimingtocaptureashareofthislucrative sector.
Pre-marketinginvolvesaseriesofstrategicactivitiesdesignedto engagekeystakeholders,includinghealthcareprofessionals (HCPs),payers,andpatients,beforeaproduct'sofficiallaunch. Researchshowsthatcompaniesthatengagestakeholdersearlycan enhancetheirmarketpresenceandavoidcostlydelaysinadoption. Forinstance,delayingengagementcanleadtomissedopportunities worthmillions,asittakestimetobuildtrustandeducatethemarket aboutnewtherapies.
Oneeffectivestrategyisleveragingdigitalplatformstoreacha broaderaudience.Infact,nearly70%ofpatientsreportusingonline resourcestolearnabouthealthconditionsandtreatments.Thisshift towardsdigitalengagementallowscompaniestoprovidevaluable informationandfosterrelationshipswithpotentialcustomers.
Moreover,incorporatingpatient-centricapproachesisvital.Today's consumersdemandtransparencyandinvolvementintheir healthcaredecisions.Byfocusingonpatientneedsandpreferences, pharmaceuticalcompaniescancreatetargetedmarketingcampaigns thatresonatewiththeiraudience.Ultimately,awell-executedpremarketingstrategynotonlypreparesthegroundforasuccessful productlaunchbutalsobuildslastingrelationshipsthatcanleadto improvedhealthoutcomesandbusinessgrowth.
Withthisinmind,InsightsSuccessbringsforthanedition, Middle East's Top 10 Pioneers in Pharma Pre-Marketing highlighting leadersinthisfieldwhoarereformingthesectorofpharmaceutical marketing.Thesepioneershavedemonstratedexceptionalforesight andinnovationintheirpre-marketingstrategies,settingbenchmarks fortheindustry.Byleveragingadvancedanalytics,theyhavebeen abletoidentifymarkettrendsandconsumerbehaviors,allowingfor moreprecisetargetingandmessaging.
Have a great read ahead!
C08. Pi Pharma Intelligence
Pre-Market Insights in Pharmaceutical Excellence
24.
Mohamed Mazen Batterjee Advancing Pharmaceutical Development
INTERVIEW WITH INSIGHTS SUCCESS
28. 38.
20. 34.
Sharon Leid Navigating Innovation in Public Relations
Vladimer Botsvadze Navigating the Intersection of Innovation and Marketing
Enhancing Marketing E ectiveness through Comprehensive Data Strategies in Pharma
Predictive Analytics: Transforming Patient Safety in Pharmaceutical Marketing
The only limit to our realization of tomorrow will be our doubts of today. , ,
- Franklin D. Roosevelt
Business
Business
Marketing
Research
Circulation
Featuring
Planet Pharmacies LLC planetme.ae y Name
fik al Managertribu on
oub ng artner
ahim Balcilar al Manager
shid Zaidi Co-founder and Managing Director
Magdy Fahmy Chief Execu ve Officer
Pi Pharma Intelligence pibusiness.ca
Nova Pharma novapharma.com
Pharma Solu ons pharmasolu onsint.com
LIFEPharma lifepharmafze.com
Mohamed Mazen Ba erjee Managing Director
Ba erjee Pharmaceu cal Factory ba erjeepharma.com
Sharon Leid Founder and CEO
NetStruc PR netstrucpr.com
Ashraf Shafik is a strategic thinker in distribu on management, enhancing opera onal efficiency and customer sa sfac on within the pharmaceu cal sector, while fostering strong partnerships across the UAE.
Hazem Al Yacoub is a strategic thinker and innova ve leader, driving transforma ve marke ng ini a ves in the pharmaceu cal sector, with a focus on enhancing customer engagement and brand visibility.
Ibrahim Balcilar is a proac ve leader commi ed to driving pharmaceu cal advancements, focusing on research and development to deliver high-quality healthcare products that meet market demands.
Khurshid Zaidi is a collabora ve entrepreneur focused on delivering effec ve pharmaceu cal solu ons, emphasizing quality and innova on to meet the evolving needs of healthcare providers.
Magdy Fahmy is a results-driven leader passionate about improving healthcare access, leveraging innova ve solu ons to enhance pharmaceu cal services and pa ent outcomes across diverse markets.
Mohamed Mazen Ba erjee is a visionary entrepreneur dedicated to advancing healthcare solu ons, emphasizing quality and accessibility in pharmaceu cal products, significantly impac ng the industry landscape.
Sharon Leid is a crea ve force in public rela ons, building impac ul narra ves and strategies that elevate brand presence, while fostering strong rela onships within the media landscape.
Tarek Hosni CEO
Jamjoom Pharma jamjoompharma.com
Tarek Hosni is a dedicated leader in the pharmaceu cal industry, commi ed to improving health outcomes through innova ve product development and strategic market posi oning.
Tareq Darwazeh Chief Opera ng Officer
Hikma Pharmaceu cals hikma.com
Tareq Darwazeh is a forward-thinking execu ve focused on opera onal excellence, driving growth and innova on in pharmaceu cal manufacturing, while fostering a culture of con nuous improvement.
Vladimer Botsvadze Business Coach
Vladimer Botsvadze vladimerbotsvadze.com
Vladimer Botsvadze is a dynamic business coach known for empowering professionals through tailored strategies, fostering growth and resilience in their personal and professional journeys.
Insights in Pharmaceu cal Excellence
Pi-insight empowers pharmaceutical companies with extensive big data analytics. This capability allows for a thorough evaluation of performance metrics and the anticipation of upcoming trends.
Hazem Al Yacoub’s illustrious 20-year career in the pharmaceutical industry, marked by diverse roles with major players such as Bayer, AstraZeneca, Ferring, and, notably, Tabuk Pharmaceuticals, underscores his deep understanding of the intricacies of the eld.
Middle East’s Top 10 Pioneers in Pharma Pre-Marke ng
Empowering Pharmaceuticals with Cutting-Edge Insights!
Somethingstaughttouswhenwewereyoungerare forevercarvedintoourminds.Itisthiswinning mindsetthatgivesusthestrengthtonevergiveup. Thisistheprocessthatmakesuscapableofhandling criticalandresponsiblesituations.Inthesameway, navigatingtheintricatelandscapeofdrugresearch, manufacturing,andmarketaccessiscrucialforsuccessin thepharmaceuticalindustry.Comprehensivepre-market analyticsareavailableatPiPharmaIntelligenceto supportyourpharmaceuticaljourney
TheexpertsatPiPharmaIntelligenceprovidevaluable insightsintothelatestbreakthroughs,emergingtrends,and researchopportunities.
Let’s unlock the journey of innovation, cutting-edge technologies, and market insights of Pi Pharma Intelligence:
Inauguratingitscommercialjourneyinlate2020,Pi PharmaIntelligenceemergedfromthevisionaryaspirations ofitsfounder,NusaibahAlJaloudi.Recognizingthe MENAregionasalinguisticentityunitedbyArabic launguage,heidentifiedacriticalchallenge—fragmented, non-standardized,andelusivedata,specificallyinthe Pharmaceuticalssector Thisdatadisparitywieldeda significantandadverseimpactonthepharmaceutical industry,leadingtoastaggering20%terminationrateof productprojectsatadvancedstages,translatinginto substantialfinanciallossesandresourcewastage.
Inresponsetothispressingneed,theinceptionofPi PharmaIntelligencesoughttointroduceadigitalsolution, harmonizingandconsolidatingpivotalpharmaceutical insightsacrosstheMENAregion.Thecompanyembarked onitsjourneywithamissiontomitigateindustry challenges,fosterinformeddecision-making,and revolutionizetheaccessibilityofessentialdatainthe regionalpharmaceuticallandscape.
PiPharmaIntelligenceemergesasatrailblazerintherealm ofpharmaceuticalintelligence,dedicatedtodelivering insightsthattranscendtraditionaldataofferings.Providing clientswithaholisticunderstandingofthepharmaceutical landscape,encompassingintricatedetailsofintellectual
property,regulatorynuances,pricingdynamics,and manufacturerinsights,thecompanyempowersitsclientele withinvaluableinformation.Withafocusonearly awarenessandproactiveupdates,Piensuresthatclientsare well-preparedtonavigaterisksandmakewell-informed decisions.
Goingbeyondtherealmofdataprovision,thecompany’s trueimpactliesinfosteringinternalcollaboration, harmonizingdepartments,andtransformingdecisionmakingintoacollaborativeandstrategicprocess.Pinot onlyservesasaninformationproviderbutalsoasa catalyst,revolutionizingthedecision-makingparadigm withinthepharmaceuticalindustry
TheStrategicCo-founderHazemAlYacoub’sillustrious 20-yearcareerinthepharmaceuticalindustry,markedby diverseroleswithmajorplayerssuchasBayer, AstraZeneca,Ferring,and,notably,TabukPharmaceuticals, underscoreshisdeepunderstandingoftheintricaciesofthe field.Thepivotalshiftinthelastsevenyearstowardsa moreinvolvedroleindecision-making,particularlyin productselectionandsourcingfortheMiddleEastand Maghrebregions,showcaseshisstrategicinsights.
Hisrecognitionoftheparamountimportanceoftimely, accurateinsightsanddatahasledtoapurposefultransition intothedynamicdomainofInsightsandAnalytics. Hazem’sjourneyreflectsadaptability,continuouslearning, andacommitmenttodrivingsuccessinanindustry undergoingrapidtransformation.
Withadedicatedteamcomprising20professionals, includingpharmacistsanddatascientists,PiPharma Intelligenceemploysameticulousprocesstocuratedata fromreputablesources.Throughrigorouscross-referencing, theteamensurestheaccuracyofthedata,addingsignificant valuebeforeintegratingitintotheplatform.Thecompany’s commitmentextendstokeepingclientswell-informedabout criticaldata,encompassingthecompleteintellectual propertylandscape,fromgrantedtopendingpatents, regulatorysubmissions,andapprovalstopricingdetailsand manufacturers’insights.
Recognizingthatthetrueessenceliesnotjustinthedata itselfbutinitsinterpretation,PiPharmaIntelligence emphasizestheimportanceofinformeddecision-making
basedoncomprehensiveinsights,offeringclientsa transformativeapproachtonavigatingthecomplexitiesof thepharmaceuticallandscape,supportedbyanexperienced team,isconsistentlyengagedininteractingwithclients. Theyconductanalyses,enhanceinsights,andpropose solutions,effectivelyaddingvaluetotheservicesprovided.
Byprioritizingthestrategicselectionofportfoliomix,the platformPi-insightempowerspharmaceuticalcompanies withextensivebigdataanalytics.Thiscapabilityallowsfor athoroughevaluationofperformancemetricsandthe anticipationofupcomingtrends.Offeringinvaluableand distinctiveinsightsintopatents—bothgrantedand pending—itprovidesatechnicalassessmentoftheclaims, ensuringthattheclientsnotonlyrespectintellectual propertyrightsbutalsosteerclearofpotentiallitigations withpatentowners.AtPi,thecommitmentliesinequipping clientswiththetoolsandinsightsnecessarytodrivetheir marketstrategy,consistentlypositioningthemaspioneers inthepharmaceuticallandscape.
AnotableachievementincludesoneofPiPharma Intelligence’sSaudiclientsregisteringthefirstoncology genericintheUAE,unlockingamarketvalueof8million USD,andsecuringawinningtendervaluedat$800,000.
Leveragingcutting-edgetechnology,PiPharma Intelligence’sproficientinformationteamhasdeveloped programsandapplicationsthatsystematicallyidentifyand collectdatafromvarioussources,ensuringconsistentand timelyupdates.
Renownedforitsdistinctiveinitiativeinstandardizingand unifyingMENAregiondata,PiPharmaIntelligencestands outastheexclusiveglobalsupplierofcomprehensive information.Theplatformiswidelyembracedbyclients seekingtocrafteffectiveaccessstrategies,identifyproduct suppliers,determinemarketranks,andstrategicallydecide onlaunchdates,solidifyingPiIntelligence’spivotalrolein steeringpharmaceuticalcompaniestowardsuccess.
Whentheylaunchedtheproduct,theywereanticipatinga significantdemandfrominvestorsandexisting pharmaceuticalcompaniesbasedinMENA.However,in thecurrentyear,theyfoundthemselvesattractingusersand clientsfromIndia,China,Turkey,andEurope.These stakeholderssawPiInsightasagatewaytocomprehending theMENAregionanditsdynamics.
PiInsightcurrentlydeliversvaluableinformationtoits clientsandusers.However,thesystemreliesonusers activelyseekingandactinguponthisinformation.In contrast,PiPharmaIntelligenceenvisionsamoreproactive approachtoensureclientsaretakingtherightsteps.To achievethis,PiPharmaIntelligenceisintheprocessof developinganewproduct.Thisinnovativesolutionwill seamlesslyintegratetheinsightsgatheredintointernal projectsateachcompany Throughthisintegration,push notificationswillbestrategicallyplacedwithincompany projects,compellingresponsibleprojectmanagerstotake promptandinformedactionsbasedontheinsights provided.Thisstrategicinitiativeaimstoenhanceefficiency andresponsivenesswithinbothPiInsightandPiPharma Intelligence,aligningwiththeircommitmenttodelivering optimalresultsfortheirclients.
,
,
Pi Pharma Intelligence emerges as a trailblazer in the realm of pharmaceutical intelligence, dedicated to delivering insights that transcend traditional data offerings.
“PiPharmaIntelligence,proventobeExpertsinwhatthey do,quicklyevolvedtobeamongthebestsolutionsutilizing Intelligencetoconfidentlydeliverup-to-dateandinsightful Data.WeareconfidenttohavePiasalong-termPartner.”
Rasha Ma’ayah
BD Director
“NotJustaPharmaCIdatabase,itisapassionof supportingthepartnerstowardsthesuccessand uniqueness.”
Ali El-Badry
Business Development Manager
“ImustsaythattheexperiencethatwehadwithPihasbeen outstanding.Thesearchoutcomecanbeconfiguredina varietyofoptions,sometimesmoreoptionsthanregular workrequires.Searchresultsanalysesareuseful.Database updatesareperformedtimely.”
Ali Aqel
Business Development Head
“Piwalkswithitsclientsalltheway,innatelyfurnishes clearviewsofthepathwayahead,andreassuresclientsby theirgenuinelyhightierstandardofservice.Pihasalways addedclaritytoourpathways.”
Iyad Saleh Eqtefan Director, RD RA & Medical Affairs
”Hereweareabouttocompleteourthirdyearof cooperationwithourstrategicpartner“PI.”Infact,theydo notstopdevelopingandimproving,andIamveryexcited totrythenewversion,whichIexpectwillbenoless perfectthanthecurrentversion.”
Dr.Soad Essam Intellectual Property head
WorkingwithPiPharmaIntelligenceisanimmense pleasureforme.Allteammembersarecooperativeand friendly Theyalwaysstayclearandconciseabout requirements,projectdetails,anddeliverables.Aperfect teamwithhighstandards!
Dr. Shama Nosheen
Medical writer
With a focus on early awareness and proactive updates, Pi ensures that clients are well-prepared to navigate risks and make wellinformed decisions. ,,
Three Compelling reasons to invest in Pi Pharma Intelligence to drive 3X growth in revenues 2025
1. Exceptional Team
40+ years of experience in pharma, tech, and data
Managed investment of 100 M USD in Pharma Ex-Tabuk , Ex-AstraZeneca , Ex-PWC
2. Scalable product
In house developed a web app that gives access to all critical data for decision-making in the pharma industry (prices, IP, Regulatory, etc.)
Customizable to different territories and markets
600,000 data points already collected
Will be revolutionized by AI
3. Market Timing
The market leader in the GCC
Expanding to East Europe through inbound (Poland, Greece, Hungary, Malta)
Addressing the next shi s in the pharmaceutical industry
We see three trends that will play a critical factor in the growth of the Pharma Industry:
European legislation reforms are facilitating exports of generic products
Analytics and AI are driving decisionmaking in Drug discovery
Post Covid National security on drugs is driving government policies and investments
Pi-Insight is the only pharma research platform in the MENA
Simple, easy, and comprehensive, it has already delivered $50m of ROI
Pi Pharma Intelligence launched specialized research platform that provides pharma companies with the pre-marketing insights and data they need for effective and improved product access planning
Pi Insight, offers BD teams instant access to drug and patent information, drug attributes, clinical trials, and other critical information. As a result, we maximize our client’s ROI.
Attributes tracked: 28
Across Markets: 8
Products Catalogued: 10K
Stop Keeping Unit: 15K
Clinical Trials Data: 75K
Patents Archived: 350K
Market Protection: 10K
Enhancingmarketing
effectivenessinthe pharmaceuticalindustryis increasinglyreliantoncomprehensive datastrategies.Asthelandscape evolves,pharmaceuticalcompanies faceuniquechallengesin understandingtheircustomersand effectivelyreachinghealthcare professionals(HCPs)andpatients.
Let us explore how leveraging data can significantly improve marketing effectiveness in pharma.
Thepharmaceuticalindustryis complex,governedbystrict regulationsandcharacterizedbya highlycompetitiveenvironment.In 2020,pharmaceuticalcompaniesinthe U.S.spentover$6.5billionondirectto-patientmarketingalone,witha significantportiondirectedtowards HCPs.Thishighlightstheindustry's focusontargetedmarketingeffortsto ensurethattherightmessagesreach therightaudiences.
Dataisattheheartofeffective marketingstrategies.Byanalyzing
diversedatasources—suchaspatient records,markettrends,andphysician prescribingbehaviors,pharmaceutical companiescangaininsightsinto consumerbehaviorandpreferences. Thisdata-drivenapproachallowsfor morepersonalizedmarketingefforts, whicharecrucialintoday'spatientcentrichealthcareenvironment.
Forinstance,predictiveanalyticscan identifypatientpopulationsthatwould benefitmostfromspecifictreatments, enhancingtheefficiencyofmarketing campaigns.Companiesthatutilizedata effectivelycanoptimizetheir marketingmixandbudgetallocation, leadingtoimprovedreturnon investment(ROI)andbetter-targeted campaigns.
Inrecentyears,patientshavebecome moreempoweredandinformedabout theirhealthcareoptions.Theyactively seekinformationonline,makingit essentialforpharmaceuticalcompanies toproviderelevantandaccessible content.Apatient-centricapproach involvestailoringmarketingeffortsto meetindividualneedsandpreferences.
Forexample,apatientusinganasthma medicationmightreceivetargeted communicationsaboutnewtreatments, usagetips,orlifestyleadvice.Thisnot onlyprovidesvaluableinformationbut alsofostersadeeperconnection betweenthepatientandthe pharmaceuticalbrand.
Theintegrationoftechnology, particularlyartificialintelligence(AI) andmachinelearning(ML),has transformedpharmaceuticalmarketing. Thesetechnologiesenablecompanies
toanalyzevastamountsofdataquickly andderiveactionableinsights. Advancedalgorithmscanmergedata fromvarioussources,suchas electronichealthrecordsandinsurance claims,improvingtheaccuracyof marketingpredictionsandstrategies.
Moreover,companiescanutilize insightsmanagementplatformsto engagewithkeyopinionleaders (KOLs)andhealthcareprofessionals throughouttheproductlifecycle.By leveragingKOLexpertise, pharmaceuticalcompaniescanenhance productawarenessandcredibility, ultimatelyinfluencingprescribing behaviors.
Asuccessfulpharmaceuticalmarketing strategymustincorporateamultichannelapproach.Thismeansutilizing variousplatforms,suchassocial media,emailmarketing,andtraditional advertising,toreachtargetaudiences effectively.Socialmedia,inparticular, hasemergedasapowerfultoolfor engagingwithpatientsandHCPs.By sharinginformativecontentand fosteringdiscussions,pharmaceutical companiescanbuildtrustandenhance theirbrandimage.
Infact,studiesshowthatvideocontent hasasignificantlyhigherengagement rate,withviewersretaining95%ofa messagewhenwatchedcomparedto just10%whenread.Thisunderscores theimportanceofcreatingengaging andinformativecontentacross multipleformatstoreachdiverse audienceseffectively
Toensuremarketingeffectiveness, pharmaceuticalcompaniesmust
continuouslymeasureandanalyzethe performanceoftheircampaigns.Key performanceindicators(KPIs)suchas engagementrates,conversionrates, andoverallROIprovidevaluable insightsintowhatstrategiesare workingandwhatareasneed improvement.Thiscontinuous feedbackloopisessentialfor optimizingmarketingstrategiesand achievingbetteroutcomes.
Forinstance,companiescantrackthe effectivenessoftheircampaigns throughmetricsthatgaugepatient engagementandHCPinteractions.By understandingwhichtacticsyieldthe bestresults,pharmaceuticalmarketers canallocateresourcesmoreeffectively andrefinetheirstrategiesaccordingly
Inconclusion,enhancingmarketing effectivenessinthepharmaceutical industryrequiresacomprehensivedata strategythatprioritizespatientneeds andleveragestechnology.By understandingconsumerbehavior, personalizingmarketingefforts,and employingamulti-channelapproach, pharmaceuticalcompaniescan navigatethecomplexitiesofthemarket andachievegreatersuccess.Asthe industrycontinuestoevolve,those whoembracedata-drivenstrategies willbebetterpositionedtomeetthe challengesaheadandfostermeaningful connectionswithpatientsand healthcareprofessionals.
Success is not how high you have climbed, but how you make a positive difference to the world.
- Roy T. Bennett
Thepharmaceuticalindustrystandsasabeaconof innovationandgrowth,continuallypushing boundariesindrugdevelopmentand manufacturing.Withafocusonproducingchemical generics,herbalmedicine,andcosmetics,thissector navigatesacomplexlandscapeofregulationsandmarket demands.
LeadingtheindustryisMohamedMazenBatterjee,the ManagingDirectorguidingtheBatterjeePharmaceutical Factorytowardsexcellence.Underhisleadership,Batterjee Pharmahasachievedremarkablemilestones,launching numerousproductsdevelopedentirelyin-houseandactively engaginginthedevelopmentofnewformulations. Mohamed’sstrategicvisionandcommitmenttoinnovation havepropelledthecompanyforward,positioningitasakey playerinthepharmaceuticallandscape.
BatterjeePharmaceuticalFactory,withitsdedicationto qualityandregulatorycompliance,hasbecome synonymouswithreliabilityandefficacyinthemarket. Throughstrategicpartnerships,adherencetointernational standards,andapatient-centricapproach,thecompany continuestostreamlineoperations,drivingefficiencyand acceleratinggrowth.Astheindustryevolvesandembraces automationandartificialintelligence,BatterjeePharma remainsattheforefront,prioritizingbothprofessional excellenceandpatientwell-being.
Let’s delve in to learn more:
AstheManagingDirectorofBatterjeePharmaceutical Factory,Mohamedspearheadsthecompany’soperationsin thedevelopmentandmanufacturingofchemicalgenerics, herbalmedicine,andcosmetics.Underhisleadership, BatterjeePharmahasachievedsignificantmilestones, includingthesuccessfullaunchof57productsdeveloped entirelywithinitsresearchanddevelopmentfacility. Currently,thecompanyisactivelyengagedinthe developmentofanadditional64productsatvariousstages ofpre-marketing.Withatrackrecordofintroducing approximately10newproductsannuallyacrossdifferent categories,alloriginatingfromin-houselaboratories, BatterjeePharmahasdemonstrateditscommitmentto innovationandexcellence.Thissuccessisattributedtoa relentlesspursuitofknowledge,strategicinvestmentsin trials,nurturinghumancapital,andaclearvisionto establishitselfasarenowneddestinationandregionalhub fordevelopmentandmanufacturing.
Inthelandscapeofpharmaceuticalpre-marketing,thereisa noticeabletrendtowardsrapidmaturationasmany countriesrecognizethesignificanceoflocalknowledgeand self-sufficiencyinmedicalsupply.Consequently,thereisa heightenedemphasisandincentivesforinvestmentinlocal
production.Thisshifthaspromptedaswiftresponsefrom theprivatesectorasitendeavorstobolsteritsknowledge base,attracttoptalents,anddevelopnewbusinessmodels thatarenotonlyprofitablebutalsosustainableforlongtermmanufacturinglocalization.Moreover,regulationsare becomingincreasinglystringent,asthereisadiminishing reliancesolelyonpeerreviewfromoverseasauthoritiesfor importedproducts,particularlyincomparisontolocally manufacturedgoods.
Thechallengesposedbytimeconstraintsandevolving regulationsrepresentsignificanthurdlesinoperations. Developingamoleculefromscratchandbringingitto marketentailsalengthyprocess,oftenspanningmonths. Moreover,regulatorychangesoccurringduringthisperiod necessitateadditionaltimeforadjustmentandcompliance.
Toaddressthesechallenges,BatterjeePharmaceutical Factoryhasimplementedefficiencymeasuresaimedat reducingthedurationofeachstepintheprocess.
Additionally,strategicpartnershipshavebeenforgedwith R&Dcenterstofacilitatecollaboration,whileinternational allianceshavebeenestablishedtoexpeditemarketaccess. Inresponsetoregulatoryfluctuations,thecompany maintainsadherencetointernationallyrecognizedstandards toensurereadinessforanylevelofchallenge.
Furthermore,collaborativeeffortswithlocalcompaniesare leveragedtoco-developproducts,enhancingbothefficiency andeffectivenessinnavigatingtheregulatorylandscape.
Varioustoolsarenowavailabletofacilitatetheacquisition ofessentialinformationandsourcesrequiredtodevelop strategicplans.Thesetoolshavesignificantlyreducedthe timerequiredforsuchactivitieswhileenhancingthe accuracyoftheobtainedinformation.Anticipated advancementsincludeexpeditedregulatorysubmissions andpatentchecksthroughtheintegrationofartificial intelligence(AI)tools.
OperatingunderthepurviewoftheSFDAprovides BatterjeePharmaceuticalFactorywithadistinctadvantage intheregulatorylandscape.Asoneofthemoststringent regulatoryauthoritiesintheregion,theSFDAensures adherencetointernationalstandards.Moreover,the companyconsistentlyalignsitspracticeswith
Mohamed Mazen Ba erjee Managing director Ba erjee Pharmaceu cal Factory
internationallyacceptedregulationsoutlinedby organizationssuchastheICHandWHO.Thiscommitment guaranteescompliancewithregulatoryrequirementsacross alljurisdictions,irrespectiveofthecountryofsubmission.
Strategiccollaborationisundeniablyaneffectiveand essentialtoolforacceleratingportfoliogrowth.These alliancessignificantlyreducetime-to-marketandstreamline theprocessofmoleculedevelopmentfrominception.
Automationandartificialintelligenceplaypivotalrolesin thestrategicinitiativesofBatterjeePharmaceuticalFactory Throughcompleteautomation,thecompanyaimsto substantiallyreducemanufacturingcosts,thereby enhancingpatienteconomiccompliance.This,inturn, fosterstheeconomicviabilityofthecompany,enabling increasedinvestmentsinresearchanddevelopment activities.Theseconceptsareintricatelywovenintothe strategiesgoverningtheupgradeoftheexistingproduction linesandtheconstructionofnewunits.
From the bustling streets of to the historic cities along the Nile, Egyptianentrepreneurs are building the future, one business at a time.
Inaneradrivenbycommunicationandperception,the
realmofpublicrelations(PR)standsasapivotalforce inshapingnarratives,influencingopinions,and elevatingbrands.TheartofPRinvolvesnavigatingthrough challengeswhilecapitalizingonopportunitiestoensure visibilityandcredibilityintheeyesofthepublic.
AsCEOofaleadingPRfirm,SharonLeidbringsawealth ofexperienceandinsighttothetable.Withaknackfor understandingtheintricaciesofherclient’sbusinesses,she goesbeyondconventionalPRapproaches,craftingtailored solutionsthatelevatebrandsandmaximizeexposure. Throughherdedicationtofosteringstrongrelationships withbothclientsandmediaplatforms,Sharonensuresthat everycampaigntranscendsmeremediacoverage,driving impactfulresultsandfosteringlong-termsuccessforher clients.
AttheheartofgroundbreakingPRcampaignslies collaboration,aprincipledeeplyingrainedintheethosof NetStrucPR Withanemphasisonopencommunication andidea-sharing,thecompanyharnessesdiverse perspectivestocraftcomprehensivestrategiesthatresonate withaudiencesandachieveclients’objectives.As businessesnavigatetheever-evolvingmedialandscape, SharonLeidandherteamstandastrustedpartners, unlockingdigitalPRsuccessandpropellingsmall businessestowardgrowthandimpactinanincreasingly competitivemarket.
PR transcends mere media interviews.It encompasses amplifying their story, enhancing brand exposure, and demonstrating credibility and expertise.
“
Let’s delve in to learn more:
MasteringPRChallenges,MaximizingOpportunities
WhenSharonlostherjobafter18years,shewas devastated.However,insteadofgivingup,sheturnedtoher expertiseinPR.Initiallychallenging,particularlywhen collaboratingwithsmallbusinesseswheresecuringpress coveragewasarduous,sheutilizedherskillstohelpthem distinguishthemselvesamidstlargercompetitors.
What sets NetStruc PR apart? Sharon’sdiversebackground ingovernment,lawenforcement,andcivilservice,coupled withherextensiveexperienceinmediaandcommunity engagement.Shepossessestheabilitytonavigateany
environmentandcultivateopportunitiesforherclients. CollaboratingwithSharonentailsmorethanmeremedia exposure;itinvolvesensuringthatyourbrandreceives visibilitythroughvariousavenues.
UnderstandingherclientsisparamountinSharon’s personalizedapproachtobusiness.Shedelvesdeeplyinto theirstrengths,weaknesses,challenges,andsuccesses throughextensiveconversationsuntilastrongconnectionis established.Furthermore,sheprioritizescultivatingrobust relationshipswithmediaplatforms.Beyondmerelypitching stories,sheextendsassistancewhenevertheyrequireit, recognizingtheimportanceofnurturingtheseconnections. Sharonemphasizesthesignificanceofrelationshipsinher approach.Additionally,sheremainsupdatedthrough continuousresearch,analyzingpreviousmediacoverage, andstrategicallyaligningherclientsforpotential opportunities.
Whenworkingwithclients,SharonemphasizesthatPR transcendsmeremediainterviews.Itencompasses amplifyingtheirstory,enhancingbrandexposure,and demonstratingcredibilityandexpertise.Whilemedia interviewsareacrucialcomponent,theyarejustonepiece ofthepuzzle.Sharonunderscoresthenecessityof employingadiverserangeoftoolsandtechniquesto achievetheseobjectives.Hence,shealsodeliversspeeches andconductstrainingsessionsonpublicity Thisapproach providesheraudienceandclientswithadeeperinsightinto herworkanditsintricacies.
Sharonregardsbeingapublicistasanartform,requiring creativityandinnovationtodevisemultipleprofessional andsuccessfulstrategiesforensuringclientsareseenand heard.
SharoninitiatedLadiesOf3rdThursdayasanetworking toolaimedatunitingbusinessowners.Emergingfroman environmentwhereknowledge-sharingwasuncommon, andentrepreneurshipwasnotthenorm,shesoughtoutlikemindedindividualsforcollaboration.Whileshecontinued toparticipateinothernetworkingevents,shewasmotivated tocreatesomethingdistinctiveforamoreenriching experience.Consequently,in2015,sheestablishedLadies of3rdThursday
Overtime,Sharonrecognizedthatattendeesrequiredmore thanjustconnections;theyneededaccesstoresourcesand opportunities.Leveragingherextensivenetwork,she sourcedhigh-qualityresourcesforhermembers.Givenher naturalinclinationasaconnector,thisendeavoraligned seamlesslywithherabilities.
DuringherundergraduateyearsatJohnJayCollege,
“ “
Incorporating digital PR strategies into the traditional approach holds paramount importance in today’s media landscape.
entrepreneurshipwasnotaprevalentfocus.Known primarilyforitsemphasisonlawenforcement,where studentstypicallyaimedforcareersaspoliceofficers, attorneys,courtandcorrectionofficers,orjudges,Sharon discoveredthroughheralumniassociationthatstudents wereexploringalternativeopportunities,whichdelighted her
WhileSharonisaccustomedtobeingatrainerwhen conductingMasterclassesonbrandvisibility,teachingat JohnJaypresentedauniqueexperience.Assumingtherole ofaneducatorfeltgratifying,especiallyassheimparteda skillshehadacquiredthroughpersonallearningwiththe assistanceofcoachesandcertifications.Thisshiftallowed hertoperceivethingsfromadifferentstandpoint.She observedthatwhilesomestudentsgraspedtheconcepts swiftly,othersencountereddifficulties,acknowledgingthat eachindividualhadtheirownreasons.
Inherclientinteractionsnow,Sharonadoptsadistinct approach,particularlywhenaddressingreservationsabout certaintechniques.Shecollaborateswiththemtoexplore
alternativemethodsthatinstillconfidencewhileachieving desiredoutcomes.Witnessingaclientexperiencethat‘aha’ momentandfeelpreparedtoprogressisprofoundly rewardingforher
Sharonviewschallengesasavenuesforpersonaland professionalgrowth.Drawingwisdomfrommentors entrenchedinthePRindustryforoverfourdecades, spanningfromtheeraoffaxmachinesandface-to-face journalistmeetingstotoday’slandscapedominatedby socialmedia,emails,andAI,sherecognizestheimperative ofadaptationandevolution.
Throughoutthistransformativejourney,Sharonremains steadfastinherbeliefintheenduringvalueofrelationships. Bycultivatingauthenticconnections,shesecuresmedia featuresforherclients.Toremainattheforefrontof industrytrends,shemaintainsacontinuouslearningethos. Shouldtherebetasksbeyondherexpertise,Sharonenlists thesupportofskilledteammembers,ensuringherclients consistentlyreceivetop-tierPRservices.
AtNetStrucPR,collaborationstandsasacornerstonefor drivingimpactfulPRcampaigns.Thecompanyplacesa premiumonfosteringopencommunicationandideasharingamongbothteammembersandclients,recognizing thevaluethatdiverseperspectivesbringtostrategic planning.Thiscollaborativeethosresultsincampaignsthat aremorecomprehensive,resonatewithaudiencesand effectivelyachieveclients’objectives.Theadvantagesof thiscollaborativemodelincludethegenerationof innovativeideas,heightenedstakeholderengagement,and, ultimately,theattainmentofgreatercampaignsuccess.
AllclientsworkingwithSharonandherteamatNetStruc PRboastsuccessstories.Oftenapproachingchallenges regardingbrandvisibilitytheystruggletoaddress,clients findsolaceintheattentivelistening,carefulevaluation,and tailoredsolutionsprovidedbySharonandherteam.
Oneofthemostfulfillingaspectsoftheirworkis witnessingthesheerdelightonclients’facesasthey encountermemorablemoments.Whetherit’sduringan interviewwithalong-admiredfigure,establishing connectionswithidealclientsthatleadtocollaborations
andnewbusinessventures,orreceivinginvitationstospeak basedonmediaappearances,theseinstancesof achievementandfulfillmentserveaspowerfulmotivatorsto consistentlydeliverimpactfulresultsfortheirclients.
IncorporatingdigitalPRstrategiesintothetraditional approachholdsparamountimportanceintoday’smedia landscape.SharonandherteamatNetStrucPRadeptlyfuse digitalplatformsintotheirPRcampaigns,harnessingthe powerofsocialnetworking,onlinepublications,and influencercollaborationstoamplifytheirreachandfoster meaningfulaudienceengagement.
Forbusinessesseekingtoharnessdigitalchannelsfor publicity,Sharonadvisesastrategicapproach.She emphasizestheimportanceofunderstandingthetarget audiencethoroughlyandselectingtheappropriateplatforms toeffectivelyreachthem.Consistentandgenuine engagementemergesasacornerstone;businessesshould prioritizethecreationofvaluablecontentthatresonates withtheiraudienceandfostersinteraction.Furthermore, Sharonhighlightsthesignificanceofmonitoringand analyzingdigitalmetricstogleanvaluableinsights, enablingtherefinementofstrategiesandtheoptimizationof performanceovertime.
Sharon’svisionforNetStrucPRiscenteredongrowthand impact.Withafocusonassistingmoresmallbusinessesand entrepreneursineffectivelycommunicatingtheirstoriesand achievingnewsworthiness,sheaimstobeacknowledged andesteemedasanindustryexpertpublicist.Herobjective istoguideclientstowardsuccessamidstanever-evolving medialandscape.
Toaddresstheevolvingneedsofclientsandtheindustry, SharonenvisionsNetStrucPRexpandingitsservices, embracingnewtechnologies,andstayingaheadof emergingtrendsinPRandmediacommunications.
Water, air and cleanness are the chief articles in my pharmacy.
- Napoleon Bonaparte
Predictiveanalyticsisapowerful
toolthatistransformingpatient safetywithinpharmaceutical marketingandhealthcare.Byutilizing vastamountsofdata,predictive analyticsenableshealthcare professionalsandpharmaceutical companiestoanticipatepotentialrisks, enhancedrugsafety,andultimately improvepatientoutcomes.
Let us explore how predictive analytics is reshaping the landscape of patient safety in the pharmaceutical industry
UnderstandingPredictiveAnalytics
Atitscore,predictiveanalytics involvesanalyzinghistoricalandrealtimedatatoidentifypatternsand trendsthatcaninformfuturedecisions. Inthecontextofhealthcare,thismeans usingdatafromvarioussources,such aselectronichealthrecords,clinical trials,andpatientdemographics,to predicthowpatientsmightrespondto certainmedicationsortreatments.This approachallowshealthcareproviders tomakemoreinformeddecisions, ultimatelyleadingtobetterpatient care.
AccordingtoareportbyPWC,the globalhealthcarepredictiveanalytics
marketisexpectedtoreach$34.1 billionby2030,growingata compoundannualgrowthrate(CAGR) of20.4%from2024to2030.This rapidgrowthunderscoresthe increasingimportanceofpredictive analyticsinthehealthcaresector, particularlyinpharmaceutical marketinganddrugsafety
EnhancingDrugSafety
Oneofthemostsignificant applicationsofpredictiveanalyticsin pharmaceuticalsisindrugsafety assessment.Byleveragingadvanced analyticstechniques,pharmaceutical companiescanevaluatepotentialrisks associatedwithdrugsbeforetheyreach themarket.Forinstance,predictive modelscananalyzedatafromprevious adverseeventreportstoidentify patternsthatmayindicateahigherrisk ofsideeffectsinspecificpatient populations.
Anotableexampleofthisistheuseof predictivemodelingin pharmacovigilance,where organizationscanuncoverhiddendrug risksbyexaminingvoluntaryadverse eventreports.Thisproactiveapproach allowscompaniestoaddresssafety concernsbeforetheyescalate,ensuring
thatpatientsareprotectedfrom unforeseencomplications.
Clinicaltrialsareessentialfortesting newdrugs,buttheycanbetimeconsumingandcostly.Predictive analyticscansignificantlystreamline thisprocessbyoptimizingpatient recruitment.Byanalyzinglarge datasets,companiescanidentify potentialcandidateswhomeetspecific eligibilitycriteria,thusincreasingthe likelihoodofsuccessfultrials.This targetedapproachnotonlysavestime butalsoreducescostsassociatedwith recruitingunsuitableparticipants.
Additionally,predictiveanalyticscan helpforecastpatientenrollmentrates andidentifypotentialchallenges, allowingcompaniestoallocate resourcesmoreeffectivelyandmitigate risks.Areportindicatesthat50%of Phase3clinicaltrialsfailduetopoor sitehealth,butpredictivemodelingcan helpdeterminewhichsitesarelikelyto succeedbasedonhistoricaldata.
Anothertransformativeaspectof predictiveanalyticsisitsrolein personalizedmedicine.Byanalyzing geneticdata,medicalhistory,and lifestylefactors,healthcareproviders cantailortreatmentplanstoindividual patients.Thispersonalizedapproach notonlyenhancestheeffectivenessof treatmentsbutalsominimizestherisk ofadversereactions.
Forexample,machinelearning algorithmscanpredictwhichpatients aremorelikelytorespondpositivelyto aspecificdrugbasedontheirunique characteristics.Thiscapabilityallows formorepreciseinterventions, ultimatelyleadingtobetterhealth outcomes.
Predictiveanalyticsalsoplaysacrucial roleinanticipatingadverseevents associatedwithdruguse.Byanalyzing datafromvarioussources,including electronichealthrecordsandpostmarketsurveillance,researcherscan detectpatternsthatindicateahigher riskofadversereactions.Thisforesight enablespharmaceuticalcompaniesto takenecessaryprecautions,suchas adjustingdosagesorissuingwarnings, toensurepatientsafety
Forinstance,predictivemodelscan evaluatetheriskofnegativeeffects followingtheadministrationof immunosuppressivedrugsinorgan transplantrecipients.Byidentifying potentialadverseeventsbeforethey occur,healthcareproviderscan implementpreventivemeasuresthat protectpatients.
Theintegrationofpredictiveanalytics intopharmaceuticalmarketingand patientsafetyisrevolutionizingthe healthcarelandscape.Byleveraging data-driveninsights,healthcare professionalscanenhancedrugsafety, optimizeclinicaltrials,andpersonalize patientcare.Asthepredictiveanalytics marketcontinuestogrow,itspotential toimprovepatientoutcomesand transformthepharmaceuticalindustry willonlyincrease.
Insummary,predictiveanalyticsisnot justatrend;itrepresentsafundamental shiftinhowhealthcareisapproached. Withtheabilitytoanticipaterisksand tailortreatments,predictiveanalyticsis pavingthewayforasaferandmore effectivehealthcaresystem.Aswe moveforward,thecontinuedadoption ofthesetechnologieswillundoubtedly leadtobetterhealthoutcomesfor patientsworldwide.
Coaching is unlocking a person's potential to maximize their growth. ,,
- John Whitmore